Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001084274 | SCV001051506 | likely benign | Dyskeratosis congenita, autosomal recessive 5; Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 3 | 2025-01-15 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000906842 | SCV001153531 | likely benign | not provided | 2017-07-01 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV002255573 | SCV002533582 | likely benign | Dyskeratosis congenita | 2021-05-18 | criteria provided, single submitter | curation | |
Ambry Genetics | RCV003169272 | SCV003882048 | likely benign | Inborn genetic diseases | 2023-02-16 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV001272195 | SCV001453925 | likely benign | Dyskeratosis congenita, autosomal dominant 1 | 2020-06-05 | no assertion criteria provided | clinical testing |